Alkem Laboratories receives 2 observations from USFDA for manufacturing facility located at St. Louis, USA

US FDA had conducted an inspection of the Company's manufacturing facility located at St. Louis, USA from 14th June, 2021 to 18th June, 2021.

At the end of the inspection, the Company has received Form 483 with two (2) observations. The Company shall submit to US FDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection.

Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.3155 as compared to the previous close of Rs. 3167.3. The total number of shares traded during the day was 14347 in over 2772 trades.

The stock hit an intraday high of Rs. 3208 and intraday low of 3056.7. The net turnover during the day was Rs. 45005999.

Source : Equity Bulls

Keywords